Private equity firm Creador in talks to buy into generic drug co Leeford Health
- Source
- The Economic Times - Industry
- Source link
- https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/private-equity-firm-creador-in-talks-to-buy-into-generic-drug-co-leeford-health/articleshow/132840847.cms
- Published
- 2026-08-03 19:34:43
- Discovered by ProcIntel
- 2026-08-03 21:13:28
- Category
- Procurement & Supply Chain News
- Geography
- India
- Organisations
- —
- Review status
- Pending
- Record type
- REAL
Summary
Private equity firm Creador is in advanced talks to acquire a stake. The firm expects to invest ₹800 crore in Leeford Healthcare. This acquisition would value the generic drugmaker at ₹8,000-₹8,500 crore. Leeford Healthcare is a diversified pharmaceutical and wellness company. This deal marks the company's first ownership dilution to an external investor.
Procurement Relevance Gate
- supplier_or_company_impact (weight 12) — matched on "acquisition"
- geographic_exposure (weight 8) — matched on "1 linked geography"
Initial Signal Assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.
A provisional, automatically-computed reading of this individual Signal, before Event extraction or human review. Not a final rating.
- Initial Significance
- 2 · Moderate (20.0/100)
- Initial Confidence
- 2 · Low (28.28/100)
- Data sufficiency Whether enough structured evidence exists to trust this Signal's Initial Confidence reading. 'Sufficient' has no cap; 'Partial' and 'Insufficient' cap Confidence until more evidence is available; 'Not Assessed' means the Signal did not pass the Relevance Gate.
- Partial
- Strongest contributor
- Likely Event Severity
- Limiting factor
- Geographic Breadth
Initial Significance Moderate (20.0/100). Strongest contributor: Likely Event Severity (12.0/30 points). Limiting factor: Geographic Breadth (0.0/10 points). Initial Confidence Low (28.28/100, data sufficiency: Partial). Strongest contributor: Source Authority (20.0/40 points). Limiting factor: Specificity (0.0/20 points).
- No eligible (non-geographic, non-fictional) entities were linked to this Signal.
- no confidence-specificity evidence (actor entity, date, quantified value, or concrete verb)
- no actor entities (only attribution/metadata, if any)
- no actor content-derived geography
- single source only
- Only source-level entity metadata was available.
- Only source-level geography metadata was available.
- Source metadata did not contribute to Initial Confidence.
Linked Canonical Event(s): Private equity firm Creador in talks to buy into generic drug co Leeford Health
Methodology signal_scoring_v1 — calculated 2026-08-03 21:13:28.